E3 ligase SOCS3 regulates NOD2 expression by ubiquitin proteasome system in lung cancer progression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
E3 ligase SOCS3 regulates NOD2 expression by ubiquitin proteasome system in lung cancer progression
Authors
Keywords
-
Journal
CELLULAR ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-01
DOI
10.1007/s13402-023-00896-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Emerging roles of suppressor of cytokine signaling 3 in human cancers
- (2021) Lirui Dai et al. BIOMEDICINE & PHARMACOTHERAPY
- NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway
- (2020) Xiaomin Ma et al. Cell Death & Disease
- Sequential ubiquitination of p53 by TRIM28, RLIM, and MDM2 in lung tumorigenesis
- (2020) Jun-O Jin et al. CELL DEATH AND DIFFERENTIATION
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Blockade of EGFR Activation Promotes TNF-Induced Lung Epithelial Cell Apoptosis and Pulmonary Injury
- (2019) Toshimitsu Yamaoka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peritumoral Monocytes Induce Cancer Cell Autophagy to Facilitate the Progression of Human Hepatocellular Carcinoma
- (2018) Dong-Ping Chen et al. Autophagy
- Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma
- (2018) Li-Hua Jiang et al. Clinics and Research in Hepatology and Gastroenterology
- Antagonizing NOD2 Signaling with Conjugates of Paclitaxel and Muramyl Dipeptide Derivatives Sensitizes Paclitaxel Therapy and Significantly Prevents Tumor Metastasis
- (2017) Yi Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- NOD2 Suppresses Colorectal Tumorigenesis via Downregulation of the TLR Pathways
- (2017) S.M. Nashir Udden et al. Cell Reports
- Association of Uba6-Specific-E2 (USE1) With Lung Tumorigenesis
- (2016) Seong-Jin Kim et al. JNCI-Journal of the National Cancer Institute
- Novel therapeutic targets on the horizon for lung cancer
- (2016) Wan-Ling Tan et al. LANCET ONCOLOGY
- Association of Uba6-Specific-E2 (USE1) With Lung Tumorigenesis
- (2016) Seong-Jin Kim et al. JNCI-Journal of the National Cancer Institute
- SOCS3 and its role in associated diseases
- (2015) Yanlin Yin et al. HUMAN IMMUNOLOGY
- NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
- (2014) Roberta Caruso et al. IMMUNITY
- The biology and mechanism of action of suppressor of cytokine signaling 3
- (2012) Jeffrey J. Babon et al. GROWTH FACTORS
- Proteasomal Degradation of Nod2 Protein Mediates Tolerance to Bacterial Cell Wall Components
- (2012) Kyoung-Hee Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhancement of leptin receptor signaling by SOCS3 deficiency induces development of gastric tumors in mice
- (2012) K Inagaki-Ohara et al. ONCOGENE
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- NF-κB promotes epithelial–mesenchymal transition, migration and invasion of pancreatic carcinoma cells
- (2010) Harald J. Maier et al. CANCER LETTERS
- Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma
- (2010) Mingzhen Ying et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Immune Regulation of Cancer
- (2010) Mary L. Disis JOURNAL OF CLINICAL ONCOLOGY
- The roles of TLRs, RLRs and NLRs in pathogen recognition
- (2009) T. Kawai et al. INTERNATIONAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search